Myths vs facts: TCF7L2 and Allergie

The claim that TCF7L2 variants are directly linked to allergies is a myth. TCF7L2 is a well-established gene for type 2 diabetes risk (strong GWAS evidence). Some studies have explored its role in immune regulation or inflammation, but the evidence for allergic diseases is weak, inconsistent, and not replicated. Consumer DNA tests that mention TCF7L2 in an allergy context overstate the science. Fact: TCF7L2 primarily affects glucose metabolism; there is no robust evidence connecting it to conditions like hay fever, food allergy, or asthma. For allergy genetics, look at established loci such as HLA, IL13, or FCER1A. Be cautious: allergy genetics is polygenic and heavily influenced by environment; a single variant cannot predict allergy risk reliably.